Compounds > dioscin
Page last updated: 2024-09-03

dioscin and Carcinoma, Epidermoid

dioscin has been researched along with Carcinoma, Epidermoid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Cui, L; Fang, X; Lu, G; Yang, G; Yao, Y; Ye, J; Zeng, Z; Zhou, J1
Chen, X; Fu, X; Gu, W; Tian, H; Wang, Y; Wen, Y; Zhang, Y1

Other Studies

2 other study(ies) available for dioscin and Carcinoma, Epidermoid

ArticleYear
Dioscin facilitates ROS-induced apoptosis via the p38-MAPK/HSP27-mediated pathways in lung squamous cell carcinoma.
    International journal of biological sciences, 2020, Volume: 16, Issue:15

    Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Diosgenin; HSP27 Heat-Shock Proteins; Lung; Mice; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species

2020
Dioscin inhibits SCC15 cell proliferation via the RASSF1A/MST2/YAP axis.
    Molecular medicine reports, 2021, Volume: 23, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Diosgenin; Humans; Mouth Neoplasms; Protein Serine-Threonine Kinases; Serine-Threonine Kinase 3; Transcription Factors; Tumor Suppressor Proteins; YAP-Signaling Proteins

2021